$8.70
-0.11-1.25%
At Close: -
$8.89
0.192.18%
After Hours: Sep 20, 5:03 PM EDT
15 minutes delayed
Amneal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amneal Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $0.16 | $0.14 | 14.3 % |
Mar 2024 | 2024-05-03 | $0.14 | $0.09 | 55.6 % |
Dec 2023 | 2024-03-01 | $0.14 | $0.09 | 55.6 % |
Sep 2023 | 2023-11-07 | $0.19 | $0.13 | 46.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $701.78M | $658.14M | 6.63 % |
Mar 2024 | 2024-05-03 | $659.19M | $619.03M | 6.49 % |
Dec 2023 | 2024-03-01 | $616.98M | $634.23M | -2.72 % |
Sep 2023 | 2023-11-07 | $620.04M | $595.27M | 4.16 % |
Amneal Pharmaceuticals (AMRX) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.
The Actual EPS was $0.16, which beat the estimate of $0.14.
The Actual Revenue was $701.8M, which beat the estimate of $658.1M.
Browse earnings estimates, EPS, and revenue on all stocks.